Researchers in the US have developed a new drug that can be delivered directly into the eye via an eye dropper to shrink down and dissolve cataracts - the leading cause of blindness in humans. While the effects have yet to be tested on humans, the team from the University of California, San Diego hopes to replicate the findings in clinical trials and offer an alternative to the only treatment that’s currently available to cataract patients - painful and often prohibitively expensive surgery. Affecting tens of millions of people worldwide, cataracts cause the lens of the eye to become progressively cloudy, and when left untreated, can lead to total blindness. This occurs when the structure of the crystalline proteins that make up the lens in our eyes deteriorates, causing the damaged or disorganized proteins to clump and form a milky blue or brown layer. While cataracts cannot spread from one eye to the other, they can occur independently in ...